ProtaGene GmbH
ProtaGene is a leading global analytic CRO and a recognized expert for analytical services in protein science and cell and gene therapy. The company is a best-in-class partner for the biopharmaceutical industry worldwide to benefit from the most advanced, integrated and complete analytic services capabilities and platforms in biopharmaceutical development, from clone selection through drug approval to commercialization.
In working together with their pharmaceutical partners, the ProtaGene teams generate best-in-class analytic data packages and provide scientific, technical and regulatory support to advance, de-risk and accelerate all stages of biopharmaceutical development, including biosimilar development, of the highest quality from clone through clinic.
With 25 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry.
We support biosimilar developers with a broad range of analytical methods and consulting in achieving and demonstrating biosimilarity. For developing new biological entities (NBEs) we support customer approaches through single-source service with full analytical support, complete documentation and outstanding project management to gain market success.
200-249
1997
Pharma und Medizintechnik
